Back to
Northern Trust Corp.
SKYE
Showing 8 of 9 quarters
Position history for
Northern Trust Corp.'s holdings in Skye Bioscience, Inc.
Yes. Northern Trust holds 56,327 shares of SKYE (Skye Bioscience), worth $39,052, as of its Q2 2026 13F filing. It increased the position by 36,185 shares (+179.7%) from Q1 2026. Northern Trust has held SKYE in every 13F on record since Q2 2024, 9 quarterly filings.
Current Value
$39,052
Current Shares
56,327
Total Value Change
-$511,797
Total Shares Change
-84,555
Quarter-by-Quarter History
Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., Baker Bros. Advisors LP